If you are a founder with a venture capital term sheet in your inbox, you’re not “almost closed.” You’re at the moment where a few pages of business terms quietly lock in years of economics and control for your startup. A VC term sheet is a short summary of the key terms of a proposed preferred stock financing and it becomes the roadmap for the definitive documents, often based on NVCA-style forms.
I’m assuming you’re a founder or CEO of a Delaware C-Corp in a priced round (often Series A, sometimes Series Seed), and you’re negotiating with an institutional lead. Even that isn’t your exact fact pattern, this article will still be useful. Here’s a useful decision rule: if a term affects (1) who gets paid first at exit or (2) who can block major company actions, treat it as “real,” even if the term sheet says it’s non-binding.
What this venture capital term sheet guide covers
This is a founder-focused, investor-aware walkthrough of the core terms you’ll see in a venture capital term sheet, what’s usually standard, and where negotiation actually changes outcomes. It’s written to help you respond to a term sheet quickly without missing the landmines.
It does not try to replace your counsel, model your exact cap table, or predict “market” for your specific company. If you’re negotiating a down round, multiple liquidation preference stack, venture debt, or a structured secondary, you’ll want a more tailored analysis.
What a venture capital term sheet is
A venture capital term sheet is a short, mostly non-binding letter that summarizes the key economics and control terms for an equity financing. In most institutional priced rounds, the term sheet maps to the definitive documents (charter, stock purchase agreement, investor rights, voting agreement, and ROFR/co-sale), often built from NVCA model legal documents.
Most of the “business deal” terms are labeled non-binding, but you should assume the parties will treat them as the baseline during drafting. Also, certain provisions are commonly written to be binding, especially confidentiality and exclusivity/no-shop.
The theory vs. reality of “non-binding”
In theory, you can sign and still walk away. In reality, once you sign a venture capital term sheet, everyone starts spending money and time as if the deal is “the deal,” and big term changes late can kill trust or reset the process.
Also, be careful with anything labeled “binding,” and be clear about what gets superseded later. Delaware case law can, in some circumstances, treat term sheet provisions as surviving unless the definitive documents clearly replace them.
Sample venture capital term sheet
How to use this: Skim the sample venture capital term sheet table, then scroll back to it as you read the economics, control, and process sections below so you can match each concept to the clause.
The table below is an example of how common venture capital term sheet terms are often presented in a priced venture capital preferred stock round. It’s for education only and should not be treated as legal advice or “market” for your deal.
Term
Sample language
Founder notes (what to watch)
ECONOMICS
Type of security
Series [A] Preferred Stock
Make sure the term sheet matches a priced preferred round (not a SAFE/note) and that the “as converted” mechanics are clear.
Amount raised
$[X] total investment (Lead: $[Y])
If there are multiple closings, confirm who controls terms and how allocations work.
Pre-money valuation
$[Pre] on a fully diluted basis (including the option pool)
“Fully diluted” definitions drive dilution. Confirm whether the increased option pool is included pre-money.
Post-money valuation
$[Pre + New money] (for reference)
Helpful for sanity-checking ownership math and for comparing offers.
Price per share
$[PPS] per share (based on $[Pre] / [FD shares])
Ask for the implied cap table showing exactly how PPS is calculated.
Option pool
Increase option pool to [X]% of fully diluted cap prior to closing
This is often a major hidden economic term. Tie size to a 12–18 month hiring plan if possible.
Liquidation preference
[1x] non-participating; preference equals original purchase price, plus declared but unpaid dividends (if any)
Model “good but not huge” exits. If participation appears, ask about caps and conversion thresholds.
Dividends
Non-cumulative dividends at [X]% when, as, and if declared by the Board; payable on an as-converted basis
Watch for cumulative dividends that accrue whether or not declared and effectively increase the preference stack.
Anti-dilution
Broad-based weighted average anti-dilution; standard exceptions (options, strategic issuances, etc.)
Confirm it’s weighted average (not full ratchet) and review the exception list carefully.
Pro rata rights
Major investors have the right to purchase their pro rata share in future financings (subject to customary limits)
Consider limiting pro rata to “Major Investors” above a meaningful threshold so rights don’t proliferate across dozens of small holders.
Avoid predictable deadlocks. Be specific about how/when the independent is selected.
Protective provisions
Approval of [majority] of Series [A] required for: new senior stock, debt > $[X], sale of company, charter amendments adverse to preferred, etc.
The veto list is normal; overbreadth is the risk. Push operational items out or add thresholds.
Drag-along
Sale approved by Board + [preferred %] + [common %] requires all holders to support the transaction (customary protections)
Confirm the approval thresholds and that minority holders get customary notice and consideration protections.
Information rights
Delivery of annual budgets, quarterly financials, and other customary reporting to major investors
Keep reporting realistic. Ensure confidentiality obligations and competitive safeguards are addressed.
PROCESS
Exclusivity / no-shop
Company agrees not to solicit or negotiate alternative financings for [30–60] days
This is a leverage shift. Limit duration, define what inbound interest you can respond to, and clarify when it ends.
Confidentiality
Term sheet and negotiations are confidential (subject to customary exceptions)
Ensure you can share with existing investors and advisors, as needed.
Drafting responsibility
Company counsel drafts the first set of definitive documents; investor counsel reviews and negotiates
Company counsel typically coordinates and drafts (or manages drafting of) the first set of documents. In practice, either side may draft depending on the round and the lead. Confirm who is “driving” the docs and timeline, and aim for a tight issue list so the first draft doesn’t sprawl.
Expenses / investor counsel reimbursement
Company reimburses investor counsel legal fees and expenses up to $[Cap], payable only at closing (no reimbursement if the deal does not close)
Fee caps are common; sometimes investor counsel fees aren’t reimbursed. Negotiate a clear cap, confirm it covers only “reasonable” fees, and avoid language that requires payment even if the financing dies.
Conditions to closing
Satisfactory diligence; execution of definitive docs; board and stockholder approvals; creation of option plan; etc.
Ask what “satisfactory diligence” means in practice and what issues are already known.
Expiration
This term sheet expires at [5pm PT] on [Date] unless extended in writing
Use the deadline to keep momentum, but don’t let an artificial clock force acceptance of bad structure.
How to read a venture capital term sheet fast
When you’re triaging a term sheet, I’d bucket terms into (1) economics, (2) control, and (3) process. Start with the clauses that change your exit math, then the clauses that give someone a veto, then the clauses that control the timeline.
A 10-minute checklist before you react to the headline valuation
Find no-shop and expiration so you know your clock.
Venture capital term sheet economics: what changes your payout
Valuation is visible. Option pool mechanics are expensive.
The headline pre-money valuation tells you the price. It doesn’t tell you the dilution. That dilution comes from the fully diluted capitalization the investor assumes, including the size and timing of the option pool. If the term sheet requires a “refreshed” option pool pre-money, you’re trading ownership for hiring flexibility, and the cost usually comes out of common holders first.
Pre-money vs. post-money valuation (and why founders get tripped up)
Pre-money valuation is the value of the company before the new investment goes in. Post-money valuation is the value after the investment. The basic relationship is: Post-money = Pre-money + New money.
Where founders get burned is that your dilution depends on the price per share and the “fully diluted” share count the investor uses, often including the existing option plan and any increase required by the term sheet. In other words, you can agree on a pre-money number and still end up selling more of the company than you think if the fully diluted capitalization is defined broadly.
Option pool increase: the quiet economics term
If the term sheet says the company will “increase the option pool to X% on a pre-money basis,” that usually means the pool gets topped up before the investor buys shares, so the dilution lands primarily on founders and other common holders. If the pool is increased post-money, the dilution is shared across everyone (including the new investors) based on the post-closing ownership.
A practical founder move is to ask: “What specific hires does this pool support over the next 12–18 months, and what’s already granted?” Then propose a pool sized to that plan (or a smaller pre-money pool plus a board-approved increase later). This is one of the cleanest ways to improve your economics without arguing about headline valuation.
Liquidation preference: downside protection and sometimes upside capture
Liquidation preference is the term that decides who gets paid first in a sale or liquidation of the company. The most common structure is “1x,” meaning investors get their money back first (or they can convert to common and take their pro rata share, whichever is better).
Participating preferred (sometimes called “double dip”) typically means the investor gets their 1x preference off the top and then also shares in remaining proceeds with common, which can materially reduce founder payouts in mid-range exits. For example, on a $2M sale where the investor put in $1M for 25%: with 1x non-participating they may take $1M; with 1x participating they may take $1M plus 25% of what’s left.
Dividends: usually “boring,” but read the fine print
Dividends in venture financings are often more about preventing cash from being paid to common without also paying preferred, not about investors expecting yearly payouts. The NVCA-style approach commonly ties preferred dividends to dividends paid on common (paid “on an as-converted basis”).
Cumulative dividends are the version to watch: they can accrue each year whether or not the company declares dividends, and then get paid later (sometimes at exit), effectively increasing what preferred is owed before common sees proceeds. They’re not always a deal-killer, but they can quietly increase the preference stack in a long time-to-exit scenario.
Anti-dilution: protection in a down round
Anti-dilution provisions adjust the preferred stock’s conversion price if you later issue shares at a lower price (a “down round”). The practical effect is that earlier preferred investors receive more shares upon conversion, shifting dilution onto common and other holders.
Broad-based weighted average anti-dilution is a common middle ground: the adjustment depends on both the price drop and how many new shares are sold (bigger down rounds cause bigger adjustments). Full ratchet is harsher because it effectively resets conversion as if the prior round happened at the new low price, regardless of the size of the down round.
If you only model one thing, model an exit where the outcome is “good but not huge” (because that’s where preferences, participation, and dividends can dominate). Then move to the control terms, because even a great economic deal can feel terrible if governance slows the company down.
Venture capital term sheet control terms: who can say “no”
Board composition: avoid governance deadlocks
Board composition is where “control” becomes real. A classic early structure is 3 seats: one common (you), one preferred (the lead), and one independent. That can work well, but only if the independent is truly independent and you have a workable process to pick them.
In practice, I keep seeing founders accept “two founders, two investors, pick the independent later” and then get stuck in a slow-motion tie. If you’re choosing between a slightly higher valuation and a board structure that lets you make decisions quickly, the board structure often pays you back more than the valuation headline.
Founder vesting (reverse vesting) and acceleration
In a priced VC round, you may see founders asked to “(re)vest” some or all of their common stock under a vesting schedule. This is often structured as reverse vesting: you already own the shares, but the company has a repurchase right if you leave before vesting.
Why it shows up: investors want to know the founding team will be around to build what they just funded. What’s negotiable is usually the scope (all shares vs a portion), any “credit” for time already served, the length of the schedule, and what counts as a good leaver/bad leaver concept in the definitive documents.
Also watch accelerated vesting on a sale of the company. “Single-trigger” acceleration (vests on a sale) is rarer in institutional rounds; “double-trigger” (sale plus termination without cause / good reason) is more common. The goal is to avoid a situation where the company sells and founders are pushed out with a large portion of their equity still unvested.
Protective provisions: the veto list that shapes your flexibility
Protective provisions (also called “veto rights”) require a class vote of preferred stockholders before you take certain actions. Think of them as speed bumps on major decisions, not day-to-day operations.
Issuing new stock or a new series of preferred
Changing the charter in ways that harm the preferred class
Taking on debt over a threshold
Selling the company or substantially all assets
Paying dividends or repurchasing stock
From the investor side, these rights are mostly about preventing “value leakage” and making sure you can’t unilaterally change the deal they just priced. The tradeoff is real: you’re trading speed and autonomy for investor comfort and, often, a willingness to lead the round.
Drag-along rights: how exits get approved (and who can force the vote)
Drag-along rights are meant to prevent a small group of stockholders from blocking a company sale that has been properly approved. In plain English, if the required approvals are met, stockholders agree to vote for the deal and sign the sale documents.
The founder-sensitive parts are (1) who can approve a sale that triggers drag-along (board + preferred + common, or something else) and (2) what protections minority holders get (same deal economics, reasonable escrow exposure, no unexpected personal liability). A drag-along can help you get to an exit; liquidation preference determines what you actually take home.
Avoid “preferred-only” drag-along; aim for approvals that include both preferred and common (and board approval).
Confirm everyone gets the same form of consideration per share class and customary notice of the transaction.
Limit small-holder obligations: escrow caps, several (not joint) liability, and no non-compete/IP “surprises” imposed on minority holders.
Information rights and pro rata: the “stay close” package
Pro rata rights give investors the ability to maintain their ownership in future financings. Founders sometimes treat this as optional “nice to have” language, but in many institutional rounds it’s part of the core bargain: early risk gets you the right to keep backing the company if it works.
If your cap table is getting crowded, you can sometimes negotiate pro rata to apply only to “major investors” or above a dollar threshold. The key is to avoid giving 30 small investors paperwork rights that slow down every future round.
“Major Investor” thresholds: a small definition with big consequences
A lot of “rights” in venture documents (information rights, pro rata rights, sometimes certain consent rights) are limited to a defined set of holders, often called “Major Investors.” That definition is usually based on either (1) a minimum dollar amount invested or (2) a minimum percentage ownership.
Why founders should care: if the threshold is too low, you can end up with dozens of people entitled to reports, notices, and pro rata paperwork. A common founder-friendly approach is to set a meaningful threshold and/or let the company update the Major Investor list as holdings change, so rights don’t “spray” across an increasingly crowded cap table.
ROFR/co-sale and founder secondary sales: what changes after VC money
Most institutional rounds include a Right of First Refusal (ROFR) and co-sale (sometimes called “tag-along”) framework in the definitive documents. In plain English: if a founder wants to sell shares, the company and/or certain investors typically get the first chance to buy them, and other investors may have the right to participate alongside the sale.
If you’re hoping for founder liquidity (a secondary sale) as part of the round, assume it’s a negotiated term. Many term sheets either prohibit founder secondary entirely at that stage or allow only a small, structured amount, because investors want your incentives tied to building value, not “taking chips off the table” too early.
Practical points to watch: who holds the ROFR (company, major investors, or both), how long they have to decide, whether there’s a minimum transfer size (to avoid constant admin), and how expenses are handled. Even if secondary isn’t on the table now, getting clean transfer mechanics makes future liquidity discussions easier.
Venture capital term sheet process terms: no-shop, fees, and the closing timeline
The clauses that feel “administrative” often have the sharpest teeth because they control your leverage. Exclusivity/no-shop typically prevents you from actively soliciting or negotiating alternative deals for a set period, while confidentiality limits what you can share.
If you have a term sheet in hand, this is often the best moment to get a quick legal review, because once you sign a no-shop, you’ve traded away time and leverage. A short review can also help you send a clean issue list back to the lead instead of negotiating by email thread.
No-shop/exclusivity: what it really restricts
A no-shop clause is less about “being polite” and more about leverage: once you agree, you’re giving the lead investor time to diligence and paper the deal while limiting your ability to create a real alternative.
Most no-shops restrict you from actively soliciting competing offers and, in many cases, from negotiating or encouraging alternative financings. The gray area is usually “passive” inbound interest, what happens if another investor reaches out, or you were already mid-conversation.
Keep the term short (often measured in weeks, not months), and tie extensions to real drafting/diligence progress.
Define what you can do with inbound interest (e.g., you can listen; you can’t negotiate) and what you must disclose (if anything).
Limit who is bound (company and founders) and avoid pulling in every employee/advisor unnecessarily.
Make sure the no-shop terminates automatically if the investor stops moving the deal forward.
If you want outside help anywhere, start here: review the no-shop language before you sign, because fixing it later is much harder.
Confidentiality: what you can share and with whom
Confidentiality provisions usually exist to prevent term sheet “shopping” and to keep sensitive diligence materials from spreading. They should still let you share the term sheet and diligence materials with your lawyers, accountants, and key advisors who are under their own duty of confidentiality.
If you need to brief existing major investors or board members, the confidentiality clause should accommodate that too. If it doesn’t, fix it early—because you don’t want to be forced to choose between compliance and informed governance.
Fees and investor counsel reimbursement: caps, timing, and fairness
In many VC rounds, the company reimburses the lead investor for a portion of their legal fees at closing. That’s not automatically “unfair”, it’s often the price of getting a lead to run point, but it should be bounded and predictable. Sometimes you can push back on this, but it can be difficult to get.
The problems happen when fee reimbursement is uncapped, payable even if the deal dies, or written so broadly that it covers unrelated work. If you’re trying to keep your round clean and your burn under control, this is a clause worth tightening.
Include a clear cap (and confirm whether it includes taxes and expenses).
Make reimbursement payable only at closing, and not if the financing doesn’t close.
Limit it to “reasonable” fees for the financing (not side projects or portfolio work).
If there are multiple investors, clarify whether reimbursement is only for lead counsel (not everyone’s counsel).
A focused term sheet review can also catch fee language that should be capped or conditioned on closing, before it becomes an avoidable cost.
Who drafts the definitive documents after the venture capital term sheet is signed
In many venture financings, company counsel coordinates the closing and drafts (or manages drafting of) the first pass of the definitive documents, with investor counsel marking them up. In others, especially when a lead investor has a strong preference, investor counsel may draft first. Either can work…the key is clarity.
Before you sign exclusivity, ask who is driving the paper and what the expected drafting schedule is. The fastest deals usually have a short term sheet issue list, a clean diligence folder, and one person empowered to make decisions…so each new doc draft doesn’t reopen settled business points.
The closing timeline: a practical week-by-week map
Week 0 (term sheet): agree the business deal, decide what’s binding, and set a realistic no-shop period.
Week 1 (diligence): investor diligence (corporate docs, IP, financials, key contracts) and cleanup of obvious gaps.
Weeks 2–3 (drafting): first drafts of charter and deal docs, issue-spotting, and negotiation of open points.
Weeks 3–4 (approvals + closing): board approval, stockholder consents, signatures, funds flow, and filing the amended charter.
This varies by deal, and the map above is just a baseline. Closings slow down when corporate housekeeping is messy (missing signed founder docs, unclear cap table), IP isn’t buttoned up (no assignment agreements), key customer contracts raise issues, or drafting balloons into renegotiating business points. If you want speed, prep diligence early and keep open issues to a short, prioritized list.
How long does it take to negotiate a term sheet and close?
Even when a term sheet moves quickly, closing a priced round usually takes longer because you still have diligence, drafting, and approvals. The week-by-week map above is a practical baseline, your deal can be faster or slower depending on complexity, responsiveness, and whether new issues pop up.
Can you change a term sheet after signing?
Sometimes. If diligence surfaces a real issue, a major term was misunderstood, or the round structure changes, parties may adjust terms. But if you try to renegotiate core economics or control without a clear trigger, expect the investor to treat it as reopening the deal, and plan for time cost and relationship cost.
What to negotiate in a venture capital term sheet
What to negotiate in a term sheet depends less on “is it negotiable” and more on your leverage and the investor’s priorities. If you have competing interest or real momentum, you can often trade across terms: you give a little on price, they give you cleaner governance, or vice versa. If you have one offer and a short runway, you should focus on the few terms that can permanently distort incentives or exit outcomes.
The 80/20 negotiation list
Liquidation preference and participation (model a few exit values).
Option pool size and whether it’s pre-money or post-money.
Board composition and how the independent gets chosen.
Protective provisions scope and thresholds.
Anti-dilution and any pay-to-play mechanics.
No-shop length, who it binds, and what “passive” inbound interest means.
Founders commonly over-optimize valuation and under-optimize “clean structure.” A slightly lower valuation with a clean 1x non-participating preference, a sane board, and a reasonable veto list can be a better outcome than a flashy valuation paired with terms that drag on every major decision.
How much can you negotiate in a venture capital term sheet?
How much can you negotiate in a term sheet? Usually more than you think on structure, and less than you think on “market” terms when you have weak leverage. Early rounds with strong demand can be quite founder-friendly. Later rounds, or rounds done under time pressure, often shift leverage toward investors, and the term sheet reflects that.
A useful framing is: “I’m not trying to win every point. I’m trying to keep the exit math and governance clean so the next round is easier.” That tells a serious investor you’re optimizing for long-term fundability, not ego.
What people confuse with or in a venture capital term sheet
A SAFE or convertible note: those are typically pre-priced instruments that convert later; a venture capital term sheet usually covers a priced preferred stock round.
A cap table “ownership percentage”: your percentage is not your payout. Preferences and participation change what your equity is worth in dollars at exit.
A commitment to fund: most term sheets say they’re not a commitment to invest until definitive documents are signed and conditions are met.
“Standard terms”: standard for one stage, sector, or year may be aggressive in another. The question is whether the term fits your leverage and your future financing path.
Venture capital term sheet red flags from the founder perspective
Participating preferred with no cap, especially stacked on prior preferences
Full ratchet anti-dilution outside true rescue financing
A board structure that creates a predictable deadlock or investor control (especially early in the startup’s lifespan)
Overbroad protective provisions that creep into operational decisions
A long no-shop with vague “no conversations” language and no clear end conditions
A “red flag” doesn’t mean the investor is bad or the term sheet is not executable. It means the term meaningfully shifts outcomes, so you should model it, ask why it’s there, and decide what you’re trading to accept it.
The venture capital term sheet practical takeaway
If you remember one thing: the venture capital term sheet is where your economics and governance get set. Don’t let the valuation headline distract you from the terms that determine payout and decision-making later.
What you should do this week
If you have one offer: ask counsel to model liquidation preference, option pool dilution, and board control before you agree to no-shop.
If you have multiple interested investors: run a short, disciplined process so the lead can’t use timeline pressure to win concessions late.
If you’re raising under time pressure: pick the one or two terms you can’t live with (often participation, harsh anti-dilution, or a deadlocking board) and spend your negotiation budget there.
In all cases: reply to the term sheet with a clean issue list. Don’t renegotiate in a 30-email thread.
Venture Capital Term Sheet FAQs
What is a venture capital term sheet?
A venture capital term sheet is a short document that summarizes the key economics (price, dilution, preferences) and control terms (board, veto rights) of a proposed preferred stock financing. It’s usually not the final contract, but it sets the baseline for the definitive documents.
Is a VC term sheet legally binding?
Most business terms in a VC term sheet are labeled non-binding. However, certain provisions are often binding (commonly confidentiality and no-shop/exclusivity), and the non-binding terms usually become the starting point for the final legal documents, so treat them as consequential.
What parts of a venture capital term sheet are typically binding?
Typically binding sections include confidentiality, no-shop/exclusivity, governing law, and sometimes cost/expense or access-to-information language. Always confirm which sections are expressly binding and how long they last.
What should founders negotiate first in a venture capital term sheet?
Start with terms that change payout and control: liquidation preference/participation, option pool size and timing, board composition, protective provisions, and no-shop length. If you only have negotiation leverage for a few points, spend it there rather than on cosmetic language.
What is liquidation preference, and why does it matter?
Liquidation preference sets who gets paid first in an exit (and how much) before common stockholders share in proceeds. It matters most in low-to-mid exits, and it can matter a lot more than valuation if your outcome isn’t a massive win.
What is participating preferred?
Participating preferred generally means preferred holders get their liquidation preference first, and then also share in the remaining proceeds with common as if they had converted. Because it can reduce common’s share in many “good but not huge” exits, founders often try to avoid it or negotiate a cap.
What is anti-dilution protection?
Anti-dilution provisions protect investors if a later financing is priced below the current round by adjusting the conversion price of preferred stock. Broad-based weighted average is generally more founder-friendly than full ratchet, which can be significantly more punitive.
What is the option pool “shuffle” in a VC term sheet?
The “option pool shuffle” is founder slang for requiring the company to increase its equity incentive pool before the financing (pre-money), which effectively shifts more dilution onto existing stockholders. The right pool size should be driven by a hiring plan, not a default percentage.
What are protective provisions?
Protective provisions are investor veto rights that require preferred approval for certain major actions (like issuing new preferred stock, taking on significant debt, or selling the company). They’re normal in VC rounds, but the scope and thresholds can dramatically affect how fast you can run the business.
What are drag-along rights?
Drag-along rights require stockholders to support and sign onto a sale of the company once it has been approved by the required groups (often the board plus specified percentages of preferred and common). They’re designed to prevent holdouts, but founders should pay close attention to the approval thresholds and the limits on minority holders’ post-closing obligations (escrow, reps, and liability).
What are pro rata rights?
Pro rata rights give an investor the ability to buy enough shares in future rounds to maintain their percentage ownership. This can be important to investors, and it can affect how much allocation is left for new investors in later rounds.
What is a “Major Investor” threshold, and why does it matter?
“Major Investor” is usually a defined term in the investor rights agreement that limits certain rights (like information rights and pro rata) to holders above a minimum investment or ownership threshold. If the threshold is too low, you can end up administering these rights for dozens of small holders, which adds friction to future financings, so the definition is worth getting right.
What is a no-shop clause, and should I agree to it?
A no-shop (exclusivity) clause limits your ability to solicit or negotiate alternative deals for a period of time while the investor drafts and diligences the financing. It’s common, but founders should pay attention to length, scope (who it binds), what inbound interest you can respond to, and what ends the restriction.
Do I need a lawyer to review a venture capital term sheet?
If you’re raising a priced VC round, a lawyer review is strongly recommended because small wording differences can translate into major economic or control shifts in the definitive documents. At minimum, you want someone who can model exit outcomes and spot governance deadlocks before you sign. If you wait to engage a lawyer after your term sheet is signed, your lawyer will have less power to negotiate on your startup’s behalf.
What is founder reverse vesting (and why does it show up in a venture capital term sheet)?
Reverse vesting is when you already own founder shares, but the company has the right to repurchase unvested shares if you leave before a vesting schedule is completed. Investors often ask for it to keep incentives aligned after a priced round. What’s negotiable is usually the portion subject to vesting, credit for time already served, and whether there’s double-trigger acceleration on a sale.
What should I send my lawyer for a review of a venture capital term sheet?
Send the clean term sheet PDF (and any edits you’ve already discussed), your current cap table, and a note on any “must-have” outcomes (for example: board control, option pool size, or avoiding participating preferred). If there are multiple offers, include the competing term sheets so your counsel can help you compare tradeoffs efficiently.
How fast can a VC term sheet review be turned around?
Timing depends on complexity (stacked preferences, unusual anti-dilution, side letters, multiple investors) and how quickly you can share your cap table and context. If a no-shop is on the table, treat review as time-sensitive, ideally you want feedback before you sign and agree to exclusivity, not after.
What does a VC term sheet review typically include?
Typically, a term sheet review flags high-impact economics and control terms, explains what’s standard vs aggressive for your situation, and gives you an issue list (and suggested fallback positions) to take back to the lead investor. It usually does not replace full deal counsel on the definitive documents, think of it as getting the roadmap right before drafting begins.
What legal documents come after the venture capital term sheet?
In a typical priced round, you’ll move from the term sheet to definitive documents such as an amended charter (amended and restated certificate of incorporation), stock purchase agreement, investor rights agreement, voting agreement, and a right of first refusal/co-sale agreement. The term sheet is the blueprint; these are the contracts that actually govern the deal.
Ryan RobertsStartup Lawyer
Ryan Roberts is a startup lawyer with more than two decades of experience advising on venture financings and M&A transactions totaling more than $1 billion. He is the author of the Amazon bestselling startup law book Acceleration.
